US Tech 100

19,385.60

-0.09%

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
USOTC
Innate Pharma (PK) (IPHYF)
Innate Pharma (PK) (IPHYF) News

IPHYF

Innate Pharma (PK) (IPHYF)

Innate Pharma (PK)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:IPHYF

1 2 3 Next >>

Date	Time	Source	Headline	Symbol	Company
06/18/2024	6:43AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
06/17/2024	5:02AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
05/14/2024	5:07AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
05/07/2024	5:03AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
03/06/2024	5:00AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
03/06/2024	5:00AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
02/21/2024	5:00AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
02/06/2024	4:05PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
02/06/2024	4:00PM	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	USOTC:IPHYF	Innate Pharma (PK)
12/19/2023	5:00AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
12/18/2023	10:40AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
12/11/2023	5:01AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
12/11/2023	5:00AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
11/27/2023	5:00AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
11/07/2023	5:01AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
10/16/2023	5:00AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
10/05/2023	5:00AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
09/22/2023	5:00AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
08/10/2023	5:00AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
06/26/2023	5:03AM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:IPHYF	Innate Pharma (PK)
06/12/2023	5:45AM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:IPHYF	Innate Pharma (PK)
06/12/2023	5:44AM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:IPHYF	Innate Pharma (PK)
06/08/2023	5:02AM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:IPHYF	Innate Pharma (PK)
06/07/2023	5:03AM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:IPHYF	Innate Pharma (PK)
05/26/2023	5:05AM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:IPHYF	Innate Pharma (PK)
05/15/2023	5:28AM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:IPHYF	Innate Pharma (PK)
05/12/2023	3:01PM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:IPHYF	Innate Pharma (PK)
05/10/2023	5:05AM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:IPHYF	Innate Pharma (PK)
05/09/2023	5:05AM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:IPHYF	Innate Pharma (PK)
04/26/2023	3:04PM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:IPHYF	Innate Pharma (PK)